Compugen (CGEN) Competitors $1.48 +0.03 (+2.07%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.50 +0.02 (+1.35%) As of 08/1/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGEN vs. UPXI, SLDB, KURA, ORKA, TERN, OPT, ATYR, SIGA, TRML, and ERASShould you be buying Compugen stock or one of its competitors? The main competitors of Compugen include Upexi (UPXI), Solid Biosciences (SLDB), Kura Oncology (KURA), Oruka Therapeutics (ORKA), Terns Pharmaceuticals (TERN), Opthea (OPT), aTyr Pharma (ATYR), Siga Technologies (SIGA), Tourmaline Bio (TRML), and Erasca (ERAS). These companies are all part of the "pharmaceutical products" industry. Compugen vs. Its Competitors Upexi Solid Biosciences Kura Oncology Oruka Therapeutics Terns Pharmaceuticals Opthea aTyr Pharma Siga Technologies Tourmaline Bio Erasca Upexi (NASDAQ:UPXI) and Compugen (NASDAQ:CGEN) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation. Which has preferable earnings & valuation, UPXI or CGEN? Compugen has higher revenue and earnings than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$16.56M24.82-$23.66MN/AN/ACompugen$27.86M4.74-$14.23M-$0.16-9.25 Does the media prefer UPXI or CGEN? In the previous week, Upexi had 7 more articles in the media than Compugen. MarketBeat recorded 10 mentions for Upexi and 3 mentions for Compugen. Upexi's average media sentiment score of 0.98 beat Compugen's score of 0.51 indicating that Upexi is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Upexi 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Compugen 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, UPXI or CGEN? Upexi has a beta of -0.58, meaning that its stock price is 158% less volatile than the S&P 500. Comparatively, Compugen has a beta of 2.61, meaning that its stock price is 161% more volatile than the S&P 500. Is UPXI or CGEN more profitable? Compugen has a net margin of -51.27% compared to Upexi's net margin of -135.86%. Compugen's return on equity of -24.51% beat Upexi's return on equity.Company Net Margins Return on Equity Return on Assets Upexi-135.86% -535.19% -122.94% Compugen -51.27%-24.51%-12.19% Do insiders and institutionals believe in UPXI or CGEN? 5.7% of Upexi shares are owned by institutional investors. Comparatively, 12.2% of Compugen shares are owned by institutional investors. 31.6% of Upexi shares are owned by insiders. Comparatively, 9.5% of Compugen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate UPXI or CGEN? Upexi currently has a consensus price target of $16.00, indicating a potential upside of 247.83%. Compugen has a consensus price target of $4.00, indicating a potential upside of 170.27%. Given Upexi's higher probable upside, equities analysts plainly believe Upexi is more favorable than Compugen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Upexi 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Compugen 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryCompugen beats Upexi on 7 of the 12 factors compared between the two stocks. Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGEN vs. The Competition Export to ExcelMetricCompugenMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$129.39M$2.99B$5.49B$9.54BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-9.2517.7428.8623.83Price / Sales4.74178.75371.4866.02Price / CashN/A41.9535.4557.96Price / Book2.398.508.275.54Net Income-$14.23M-$55.06M$3.25B$259.28M7 Day Performance-3.27%-3.99%-3.73%-4.68%1 Month Performance-14.94%9.58%4.29%4.36%1 Year Performance-15.43%6.70%25.87%17.89% Compugen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGENCompugen2.0016 of 5 stars$1.48+2.1%$4.00+170.3%-18.7%$129.39M$27.86M-9.2570Upcoming EarningsUPXIUpexi3.7435 of 5 stars$5.88-3.8%$16.00+172.1%-32.3%$546M$26M0.00130Insider TradeGap DownSLDBSolid Biosciences2.6732 of 5 stars$7.02+0.3%$15.10+115.1%-20.9%$542.61M$8.09M-2.35100Gap DownKURAKura Oncology3.3434 of 5 stars$6.20-0.5%$24.50+295.2%-70.2%$539.36M$53.88M-2.95130News CoverageUpcoming EarningsORKAOruka Therapeutics2.9487 of 5 stars$14.01-1.7%$40.38+188.2%N/A$533.53MN/A-3.11N/ANews CoverageUpcoming EarningsTERNTerns Pharmaceuticals3.6897 of 5 stars$5.95-1.7%$15.63+162.6%-29.6%$528.39MN/A-5.4640Positive NewsUpcoming EarningsOPTOpthea0.3895 of 5 stars$3.41+7.2%$1.33-60.9%+53.2%$524.84M$120K0.008Positive NewsGap UpHigh Trading VolumeATYRaTyr Pharma2.6028 of 5 stars$6.16+5.7%$20.20+227.9%+141.0%$518.90M$230K-7.6053Options VolumeGap UpHigh Trading VolumeSIGASiga Technologies1.8686 of 5 stars$7.21+1.0%N/A-30.1%$510.09M$138.72M10.7640TRMLTourmaline Bio1.574 of 5 stars$22.61+14.4%$49.33+118.2%+33.2%$507.80MN/A-7.0444Upcoming EarningsHigh Trading VolumeERASErasca2.0736 of 5 stars$1.70-2.3%$4.57+168.9%-54.7%$492.92MN/A-2.74120News CoverageGap Down Related Companies and Tools Related Companies Upexi Alternatives Solid Biosciences Alternatives Kura Oncology Alternatives Oruka Therapeutics Alternatives Terns Pharmaceuticals Alternatives Opthea Alternatives aTyr Pharma Alternatives Siga Technologies Alternatives Tourmaline Bio Alternatives Erasca Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGEN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
